The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Biotechnology,Bioengineering,Applied Microbiology and Biotechnology
Link
http://link.springer.com/content/pdf/10.1007/s10529-008-9869-0.pdf
Reference61 articles.
1. Akahoshi M, Aizawa K, Nagano S et al (2008) Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature review. Mod Rheumatol Jun 13
2. Alvarado Y, Yao X, Jumper C et al (2007) Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with Rituximab plus a short course of steroid and review of the literature. Clin Appl Thromb Hemost 13:443–448
3. Bandyopadhyay S, Raney KD, Liu Y et al (2008) AAV-2 Rep78 and HPV-16 E1 interact in vitro, modulating their ATPase activity. Biochemistry 47:845–856
4. Bi L, Lawler AM, Antonarakis SE et al (1995) Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 10:119–121
5. Bleker S, Pawlita M, Kleinschmidt JA (2006) Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging. J Virol 80:810–820
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event;The Patient - Patient-Centered Outcomes Research;2018-09-27
2. Current management of hemophilia B: recommendations, complications and emerging issues;Expert Review of Hematology;2014-08-12
3. Haemophilia B: current pharmacotherapy and future directions;Expert Opinion on Pharmacotherapy;2012-09-04
4. Efficient Nonviral Gene Therapy Using Folate-Targeted Chitosan-DNA Nanoparticles In Vitro;ISRN Pharmaceutics;2012-03-07
5. Past, present and future of hemophilia: a narrative review;Orphanet Journal of Rare Diseases;2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3